| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P50 | author | Antonio C. Wolff | Q38524069 |
| P2093 | author name string | Frederick L Brancati | |
| Claire F Snyder | |||
| Hsin-Chieh Yeh | |||
| Rachel L Derr | |||
| Bethany B Barone | |||
| Kimberly S Peairs | |||
| Kelly B Stein | |||
| P2860 | cites work | Measuring inconsistency in meta-analyses | Q27860655 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies | Q28175267 | ||
| Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older | Q34141839 | ||
| The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence | Q34500922 | ||
| Diabetes mellitus and risk of colorectal cancer: a meta-analysis | Q34562613 | ||
| Diabetes mellitus and risk of breast cancer: a meta-analysis | Q34614029 | ||
| Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer | Q36303910 | ||
| A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index | Q36614935 | ||
| Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis | Q36710824 | ||
| Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer | Q36737020 | ||
| Diversity in death certification: a case vignette approach | Q38437758 | ||
| Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit | Q39720119 | ||
| A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy | Q40241452 | ||
| Negligible influence of comorbidity on prognosis of patients with small cell lung cancer: a population-based study in the Netherlands | Q40255249 | ||
| Impact of diabetes mellitus on treatment outcomes in patients with nasopharyngeal cancer | Q40282158 | ||
| The influence of other diseases upon the outcome of colorectal cancer patients. | Q40547879 | ||
| Colorectal cancer: another complication of diabetes mellitus? | Q40859668 | ||
| Prognostic factors in advanced stage squamous cell cancer of the cervix | Q40861085 | ||
| Lung cancer in octogenarians: factors affecting long-term survival following resection | Q43453076 | ||
| Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II | Q43822468 | ||
| Survival after resection for ductal adenocarcinoma of the pancreas | Q43945731 | ||
| Stage IB squamous cell cancer of the cervix: clinicopathologic features related to survival | Q44046253 | ||
| Prognostic factors for patients with esophageal cancer treated with radiation therapy in PCS: a preliminary study. | Q44246629 | ||
| Multivariate independent prognostic factors in endometrial carcinoma: a clinicopathologic study in 181 patients: 10 years experience at the Department of Obstetrics and Gynecology of the Mainz University | Q44375972 | ||
| Abnormal glucose tolerance and the risk of cancer death in the United States | Q44471360 | ||
| Protective effect of diabetes against metastasis in patients with non-small cell lung cancer | Q44531530 | ||
| Prognostic factors in the operative and palliative treatment of pancreatic cancer. | Q44662341 | ||
| 18-Fluorodeoxyglucose positron emission tomography in predicting survival of patients with pancreatic carcinoma | Q44693487 | ||
| Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen | Q44800298 | ||
| Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy | Q44913406 | ||
| Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer | Q44929926 | ||
| Differential mechanism and prognostic impact of diabetes mellitus on patients with hepatocellular carcinoma undergoing surgical and nonsurgical treatment | Q44932270 | ||
| Diabetes mellitus and risk of endometrial cancer: a meta-analysis | Q44997757 | ||
| Comorbidity as a predictor of stage of illness for patients with breast cancer | Q45269985 | ||
| Diabetes mellitus is a recurrence-independent risk factor in patients with hepatitis B virus-related hepatocellular carcinoma undergoing resection | Q45710790 | ||
| The need for a multidisciplinary approach to cancer care | Q46145019 | ||
| Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer | Q46769210 | ||
| Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer | Q46789413 | ||
| Quality of diabetes care among cancer survivors with diabetes | Q46917923 | ||
| Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. | Q50727998 | ||
| Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. | Q51486594 | ||
| Multimorbidity and survival in older persons with colorectal cancer. | Q51771910 | ||
| Impact of endocrine and diabetes team consultation on hospital length of stay for patients with diabetes. | Q52337456 | ||
| Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. | Q52961670 | ||
| Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. | Q53568652 | ||
| Comorbidity in older surgical cancer patients: influence on patient care and outcome. | Q53818117 | ||
| Survivorship with mouth and pharynx cancer and their association with cirrhosis of the liver, marital status, and residence. | Q54068619 | ||
| The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q56528982 | ||
| Colorectal Cancer Deaths as Determined by Expert Committee and from Death Certificate | Q57780668 | ||
| Comorbidity and Survival Disparities Among Black and White Patients With Breast Cancer | Q57895974 | ||
| Impact of comorbidity on lung cancer survival | Q57895993 | ||
| Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkinʼs lymphoma | Q61830179 | ||
| Diabetes as a risk factor for death following endometrial cancer | Q63431420 | ||
| Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults | Q64133523 | ||
| The influence of nicotine abuse and diabetes mellitus on the results of primary irradiation in the treatment of carcinoma of the cervix | Q69017266 | ||
| Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival | Q71740441 | ||
| Changes in diagnostic approach and factors affecting treatment and survival of pancreatic carcinoma in a retrospective series over twelve years | Q72112715 | ||
| A preliminary outcome analysis of the Patterns of Care Study in Japan for esophageal cancer patients with special reference to age: non surgery group | Q73567196 | ||
| Factors affecting morbidity, mortality, and survival in patients undergoing Ivor Lewis esophagogastrectomy | Q73682764 | ||
| Prognostic factors for survival in invasive squamous cell vulvar carcinoma: a univariate analysis | Q74027316 | ||
| Diabetes is associated with longer survival rates in patients with malignant tumors | Q74029961 | ||
| Does diabetes mellitus influence the perioperative outcome or long term prognosis after resection of hepatocellular carcinoma? | Q74402233 | ||
| Attribution of deaths following cancer treatment | Q74472830 | ||
| Are deaths within 1 month of cancer-directed surgery attributed to cancer? | Q74472850 | ||
| Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection | Q74629352 | ||
| Minor prognostic factors in squamous cell vulvar carcinoma | Q77127360 | ||
| Screening mammogram utilization in women with diabetes | Q77292252 | ||
| The influence of gender on incidence and outcome of patients with bladder cancer in Harlem | Q77326679 | ||
| Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis | Q77922704 | ||
| Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer | Q78032941 | ||
| Predictive value of clinical features at initial presentation in pancreatic adenocarcinoma: a series of 308 cases | Q78748805 | ||
| Factors affecting the survival of 121 patients treated for endometrial carcinoma at a Polish hospital | Q78846836 | ||
| Impact of diabetes mellitus on outcomes in patients with colon cancer | Q78863604 | ||
| How meta-analysis increases statistical power | Q79245839 | ||
| The development and validation of a comorbidity index for prostate cancer among Black men | Q79291386 | ||
| Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study | Q79310426 | ||
| Endometrial carcinoma and diabetes revisited | Q79398408 | ||
| Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis | Q79958047 | ||
| Diabetes mellitus is a multivariate independent prognostic factor in endometrial carcinoma: a clinicopathologic study on 313 patients | Q80266827 | ||
| Primary clinical analysis of medical disorders in Chinese women with endometrial carcinoma | Q80268157 | ||
| Longterm outcomes of early-stage gastric carcinoma patients treated with laparoscopy-assisted surgery | Q80398251 | ||
| Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitis | Q80488833 | ||
| Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma | Q80977963 | ||
| Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer | Q81547935 | ||
| The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study | Q81574365 | ||
| Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy | Q83304081 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | patient | Q181600 |
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 2754-2764 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis | |
| P478 | volume | 300 |
| Q37367496 | A Pilot Study Evaluating Steroid-Induced Diabetes after Antiemetic Dexamethasone Therapy in Chemotherapy-Treated Cancer Patients |
| Q36294159 | A dangerous liaison: Leptin and sPLA2-IIA join forces to induce proliferation and migration of astrocytoma cells |
| Q38103727 | A molecular rheostat at the interface of cancer and diabetes |
| Q100633876 | A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time |
| Q35620111 | A prospective study of the associations between treated diabetes and cancer outcomes |
| Q92151377 | A simple screening score to predict diabetes in cancer patients: A Korean nationwide population-based cohort study |
| Q49486668 | A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus |
| Q38374279 | Addressing limitations in observational studies of the association between glucose-lowering medications and all-cause mortality: a review |
| Q27331637 | Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment |
| Q46108096 | Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention. |
| Q41521328 | Advanced glycation end products promote ChREBP expression and cell proliferation in liver cancer cells by increasing reactive oxygen species |
| Q93357270 | An integrative theory for cancer (Review) |
| Q37960818 | Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cancer progression and survival: a systematic review. |
| Q38833040 | Antidiabetic exendin-4 activates apoptotic pathway and inhibits growth of breast cancer cells |
| Q38250719 | Antihyperglycaemic therapies and cancer risk |
| Q47439755 | Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced mortality. |
| Q35841445 | Association Between Television Viewing Time and All-Cause Mortality: A Meta-Analysis of Cohort Studies |
| Q35043363 | Association between diagnosed diabetes and self-reported cancer among U.S. adults: findings from the 2009 Behavioral Risk Factor Surveillance System |
| Q37193432 | Association between metformin therapy and mortality after breast cancer: a population-based study |
| Q39329097 | Association between periodontitis needing surgical treatment and subsequent diabetes risk: a population-based cohort study. |
| Q57266723 | Association between tamoxifen treatment and diabetes |
| Q36278009 | Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study. |
| Q41309175 | Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study |
| Q35625459 | Association of type 2 diabetes mellitus and the risk of colorectal cancer: A meta-analysis and systematic review. |
| Q36059690 | Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production |
| Q30248629 | BET bromodomain proteins and epigenetic regulation of inflammation: implications for type 2 diabetes and breast cancer. |
| Q37328339 | Biomarkers of the metabolic syndrome and breast cancer prognosis. |
| Q41266143 | Body mass index, diabetes and survival after diagnosis of endometrial cancer: A report from the HUNT-Survey |
| Q84408315 | Cancer and diabetes: are we ready for prime time? |
| Q33608038 | Cancer biology in diabetes |
| Q38215557 | Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment |
| Q35154853 | Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort |
| Q54570063 | Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. |
| Q35842470 | Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis |
| Q42104158 | Cancer risk in patients with diabetic nephropathy: A retrospective cohort study in Hong Kong |
| Q35104958 | Cancer risk in type 2 diabetes mellitus: metabolic links and therapeutic considerations |
| Q51370357 | Categories of glucose tolerance and continuous glycemic measures and mortality. |
| Q40483088 | Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors. |
| Q38684987 | Chemotherapy and Glycemic Control in Patients with Type 2 Diabetes and Cancer: A Comparative Case Analysis |
| Q46215779 | Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance |
| Q44974924 | Clinical characteristics and prognostic factors of adenoid cystic carcinoma of the head and neck |
| Q45093278 | Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes |
| Q34662865 | Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer |
| Q34168190 | Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance) |
| Q34338613 | Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey |
| Q55018781 | Competing risks of cancer mortality and cardiovascular events in individuals with multimorbidity. |
| Q47742516 | Cumulative evidence for relationships between multiple variants in the VTI1A and TCF7L2 genes and cancer incidence |
| Q33596314 | Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations and risk for pancreatic adenocarcinoma |
| Q89478067 | Diabetes Medication Use in Association with Survival among Patients of Breast, Colorectal, Lung, or Gastric Cancer |
| Q50075098 | Diabetes Mellitus and the Colon |
| Q84805451 | Diabetes and Cancer |
| Q92418413 | Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment |
| Q91658562 | Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance) |
| Q38000089 | Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer |
| Q34069053 | Diabetes and cancer I: risk, survival, and implications for screening |
| Q38097984 | Diabetes and cancer relationships |
| Q33759594 | Diabetes and cancer: Associations, mechanisms, and implications for medical practice |
| Q27686977 | Diabetes and cancer: a consensus report. |
| Q35110355 | Diabetes and cancer: is diabetes causally related to cancer? |
| Q26822753 | Diabetes and cancer: two diseases with obesity as a common risk factor |
| Q92669981 | Diabetes and its Potential Impact on Head and Neck Oncogenesis |
| Q40037417 | Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime. |
| Q28072665 | Diabetes and mortality in patients with prostate cancer: a meta-analysis |
| Q34634263 | Diabetes and pancreatic cancer |
| Q62583471 | Diabetes and prognosis in a breast cancer cohort |
| Q37681752 | Diabetes and prognosis in older persons with colorectal cancer. |
| Q36637909 | Diabetes and risk of cancer |
| Q38429945 | Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan |
| Q40503625 | Diabetes as a risk factor of hospitalization in the surgical ward due to cancer in the elderly and middle-aged population. |
| Q30299911 | Diabetes management before and after cancer diagnosis: missed opportunity |
| Q34662845 | Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. |
| Q37936906 | Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. |
| Q38793870 | Diabetes mellitus and long-term mortality of ovarian cancer patients. A systematic review and meta-analysis of 12 cohort studies |
| Q34615282 | Diabetes mellitus and ovarian cancer: more complex than just increasing risk |
| Q26864963 | Diabetes mellitus and poorer prognosis in hepatocellular carcinoma: a systematic review and meta-analysis |
| Q41961130 | Diabetes mellitus increases postoperative mortality in non-small cell lung cancer |
| Q38234432 | Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies |
| Q84049962 | Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease |
| Q40308936 | Diabetes mellitus not an unfavorable factor on the prognosis of hepatitis C virus-related hepatocellular carcinoma |
| Q50050603 | Diabetes mellitus: A significant co-morbidity in the setting of lung cancer? |
| Q38232006 | Diabetes mellitus: influences on cancer risk |
| Q37972673 | Diabetes, cancer, and metformin: connections of metabolism and cell proliferation |
| Q36301365 | Diabetic angiopathy and angiogenic defects |
| Q38728033 | Diabetology and oncology meet in a network model: union is strength |
| Q88782225 | Differences in cancer survival among white and black cancer patients by presence of diabetes mellitus: Estimations based on SEER-Medicare-linked data resource |
| Q48469516 | Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era. |
| Q36078978 | Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis |
| Q37924944 | Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types? |
| Q38086101 | Do statins cause diabetes? |
| Q92666125 | Does chemoradiotherapy benefit elderly patients with esophageal squamous cell cancer? A propensity-score matched analysis on multicenter data (3JECROG R-03A) |
| Q54732953 | Does diabetes therapy influence the risk of cancer? |
| Q34904669 | Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. |
| Q39417681 | Does the hospitalization after a cancer diagnosis modify adherence to process indicators of diabetes care quality? |
| Q38851473 | Does the pathophysiology of heart failure prime the incidence of cancer? |
| Q38001521 | Does use of metformin protect against cancer in Type 2 diabetes mellitus? |
| Q36825392 | Downregulation of O-linked N-acetylglucosamine transferase by RNA interference decreases MMP9 expression in human esophageal cancer cells. |
| Q89527593 | Drp1 mediates high glucose-induced mitochondrial dysfunction and epithelial-mesenchymal transition in endometrial cancer cells |
| Q36557279 | Dynamic cellular and molecular modulations of diabetes mediated head and neck carcinogenesis |
| Q36882604 | Effect of Comorbidity on Postoperative Survival Outcomes in Patients with Solid Cancers: A 6-Year Multicenter Study in Taiwan |
| Q36310097 | Effect of Diabetes Mellitus on Survival in Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis |
| Q36182971 | Effect of Diabetes on Survival after Resection of Pancreatic Adenocarcinoma. A Prospective, Observational Study |
| Q30318441 | Effect of diabetes mellitus on the outcome of patients with resected non-small cell lung carcinoma |
| Q36047132 | Effect of elevated basal insulin on cancer incidence and mortality in cancer incident patients: the Israel GOH 29-year follow-up study |
| Q35586709 | Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival |
| Q53710626 | Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. |
| Q41547828 | Effects of alcohol drinking and smoking on pancreatic ductal adenocarcinoma mortality: A retrospective cohort study consisting of 1783 patients |
| Q36677131 | Effects of cancer comorbidity on disease management: making the case for diabetes education (a report from the SOAR program). |
| Q58694444 | Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis |
| Q40119676 | Elevated Squamous Cell Carcinoma Antigen, Cytokeratin 19 Fragment, and Carcinoembryonic Antigen Levels in Diabetic Nephropathy |
| Q37660417 | Elevated hemoglobin A1c levels are associated with worse survival in advanced pancreatic cancer patients with diabetes |
| Q30234587 | Energy sensing pathways: Bridging type 2 diabetes and colorectal cancer? |
| Q34520129 | Epidemiology and outcomes of previously undiagnosed diabetes in older women with breast cancer: an observational cohort study based on SEER-Medicare. |
| Q38202569 | Epidemiology of infections in cancer patients |
| Q40781176 | Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study |
| Q35015365 | Exercise training prevents endometrial hyperplasia and biomarkers for endometrial cancer in rat model of type 1 diabetes |
| Q48152525 | Exploratory study of impact of cancer-related posttraumatic stress symptoms on diabetes self-management among cancer survivors. |
| Q45172696 | Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues |
| Q48229894 | Fasting Blood Glucose Level in Locally Advanced Non-Small Cell Lung Cancer: a New Prognostic Factor? |
| Q36594091 | Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type |
| Q92626476 | Fasting blood glucose levels and prognosis in patients with non-small-cell lung cancer: a prospective cohort study in China |
| Q64117465 | Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy |
| Q61450753 | Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors |
| Q92908989 | General practitioners' perspectives on chronic care consultations for patients with a history of cancer: a qualitative interview study |
| Q93235386 | Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project |
| Q37364601 | Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study |
| Q37859317 | Glucose metabolism disorders and the risk of cancer. |
| Q37525828 | Glucose promotes breast cancer aggression and reduces metformin efficacy. |
| Q33632814 | Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis |
| Q33935606 | Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma |
| Q40823795 | Glycemic Status and Infection Risk in Nondiabetic Autologous Hematopoietic Cell Transplantation Recipients |
| Q87926734 | Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus |
| Q35571394 | Glycogen synthase kinase (GSK)-3 promotes p70 ribosomal protein S6 kinase (p70S6K) activity and cell proliferation |
| Q45735011 | Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1. |
| Q47933245 | Glycosylated Hemoglobin A1c and Lack of Association With Symptom Severity in Patients Undergoing Chemotherapy for Solid Tumors |
| Q40125992 | Guideline-Based Statin Eligibility, Cancer Events, and Noncardiovascular Mortality in the Framingham Heart Study |
| Q36467480 | Health management in cancer survivors: Findings from a population-based prospective cohort study-the Yamagata Study (Takahata) |
| Q92067825 | Health status of middle-aged and older cancer survivors: a nationwide cross-sectional study from the China Health and Retirement Longitudinal Study (CHARLS) |
| Q64056215 | High glucose promotes pancreatic cancer cells to escape from immune surveillance via AMPK-Bmi1-GATA2-MICA/B pathway |
| Q53176133 | High-density lipoprotein of patients with breast cancer complicated with type 2 diabetes mellitus promotes cancer cells adhesion to vascular endothelium via ICAM-1 and VCAM-1 upregulation. |
| Q50998457 | Hyperglycemia Promotes Human Gastric Carcinoma Progression via Aquaporin 3. |
| Q42339288 | Hyperglycemia exacerbates colon cancer malignancy through hexosamine biosynthetic pathway |
| Q33594115 | Hyperglycemia, a neglected factor during cancer progression |
| Q36393112 | Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes |
| Q37272484 | Hypertriglyceridemia is frequent in endometrial cancer survivors |
| Q44882597 | Hypoxia negates hyperglycaemia-induced chemo-resistance in breast cancer cells: the role of insulin-like growth factor binding protein 2. |
| Q38844045 | IFN-β is a potent inhibitor of insulin and insulin like growth factor stimulated proliferation and migration in human pancreatic cancer cells. |
| Q36489031 | Imbalance of angiogenesis in diabetic complications: the mechanisms |
| Q28082544 | Impact of Age and Comorbidity on Cervical and Breast Cancer Literacy of African Americans, Latina, and Arab Women |
| Q87856651 | Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011 |
| Q53623499 | Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes. |
| Q90416553 | Impact of diabetes mellitus on outcomes in patients with brain metastasis treated with stereotactic radiosurgery |
| Q52657234 | Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis. |
| Q34043430 | Impact of hyperglycemia on survival and infection-related adverse events in patients with metastatic colorectal cancer who were receiving palliative chemotherapy. |
| Q35290403 | Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation |
| Q35063344 | Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis |
| Q34609703 | Impact of type 2 diabetes mellitus on the prognosis of early stage triple-negative breast cancer in People's Republic of China |
| Q37618858 | Impact of undetected comorbidity on treatment and outcomes of breast cancer |
| Q42138621 | Importance of Glycemic Control in Cancer Patients with Diabetes: Treatment through End of Life |
| Q64117920 | Incidence and relative risk for developing cancers in women with gestational diabetes mellitus: a nationwide cohort study in Taiwan |
| Q64942814 | Incidence of Diabetes After Cancer Development: A Korean National Cohort Study. |
| Q34803251 | Increased cancer mortality in diabetic people treated with insulin: a register-based follow-up study |
| Q42153153 | Increased mortality for colorectal cancer patients with preexisting diabetes mellitus: an updated meta-analysis |
| Q34354362 | Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China |
| Q89590994 | Influence of Preexisting Diabetes on Survival After a Breast Cancer Diagnosis in First Nations Women in Ontario, Canada |
| Q45908971 | Influence of diabetes mellitus on mortality in breast cancer patients. |
| Q39063925 | Insights into the relationships between diabetes, prediabetes, and cancer |
| Q44027980 | Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy |
| Q92653227 | Insulin Resistance and Cancer-Specific and All-Cause Mortality in Postmenopausal Women: The Women's Health Initiative |
| Q38155073 | Insulin and IGFs in obesity-related breast cancer |
| Q42756047 | Insulin concerns and promises |
| Q43418713 | Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up. |
| Q37994048 | Insulin-like growth factors and insulin: at the crossroad between tumor development and longevity |
| Q34157626 | Insulin-mediated acceleration of breast cancer development and progression in a nonobese model of type 2 diabetes |
| Q33688576 | Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression |
| Q58592781 | Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors o |
| Q27011756 | Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies |
| Q35211957 | Korean type 2 diabetes patients have multiple adenomatous polyps compared to non-diabetic controls |
| Q37547661 | Lactate, a Neglected Factor for Diabetes and Cancer Interaction. |
| Q33588852 | Latest insights into the risk of cancer in diabetes |
| Q38040433 | Life-style and metformin for the prevention of endometrial pathology in postmenopausal women |
| Q37770717 | Linking diabetes and cancer: a consensus on complexity |
| Q44921293 | Linking prediabetes and cancer: a complex issue. |
| Q89531610 | Local and Systemic Immune Dysregulation Alters Glioma Growth in Hyperglycemic Mice |
| Q35936700 | Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer |
| Q37279091 | Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey. |
| Q33849666 | Mammalian target of rapamycin inhibition abrogates insulin-mediated mammary tumor progression in type 2 diabetes |
| Q33777669 | Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model |
| Q38264231 | Management of diabetes in patients with cancer |
| Q37154242 | Mechanisms linking obesity and cancer |
| Q33956785 | Medical comorbidities predict mortality in women with a history of early stage breast cancer |
| Q43855228 | Medically managed hypercholesterolemia and insulin-dependent diabetes mellitus preoperatively predicts poor survival after surgery for pancreatic cancer |
| Q34608171 | Menopause care for obese and diabetic women. |
| Q64122520 | Metabolic Alterations, Aggressive Hormone-Naïve Prostate Cancer and Cardiovascular Disease: A Complex Relationship |
| Q90176440 | Metabolic Health, Insulin, and Breast Cancer: Why Oncologists Should Care About Insulin |
| Q38142797 | Metabolic syndrome and cancer: holistic or reductionist? |
| Q57559362 | Metabolic syndrome and endometrial cancer risk |
| Q34539016 | Metabolic syndrome and outcomes following early-stage breast cancer |
| Q37191427 | Metabolic syndrome and pre-diabetes contribute to racial disparities in breast cancer outcomes: hypothesis and proposed pathways |
| Q40161015 | Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer |
| Q36478779 | Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis |
| Q39714372 | Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer |
| Q33611185 | Metformin and breast cancer stage at diagnosis: a population-based study |
| Q34159241 | Metformin and cancer |
| Q36800716 | Metformin and cancer in type 2 diabetes |
| Q50105959 | Metformin and cancer: An existing drug for cancer prevention and therapy |
| Q33668168 | Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality |
| Q26738743 | Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis |
| Q43063833 | Metformin, cancer, alphabet soup, and the role of epidemiology in etiologic research |
| Q35764409 | Metformin: multi-faceted protection against cancer |
| Q94496697 | MnTE-2-PyP, a manganese porphyrin, reduces cytotoxicity caused by irradiation in a diabetic environment through the induction of endogenous antioxidant defenses |
| Q28253823 | Molecular mechanisms of cancer development in obesity |
| Q57734588 | Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment |
| Q35688186 | Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival |
| Q43410841 | Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy |
| Q36020137 | Multi-institutional analysis of pancreatic adenocarcinoma demonstrating the effect of diabetes status on survival after resection |
| Q36485355 | Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer |
| Q51323360 | New prognostic model for extranodal natural killer/T cell lymphoma, nasal type. |
| Q34101569 | New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts |
| Q34172895 | O-GlcNAc signaling: a metabolic link between diabetes and cancer? |
| Q36682124 | O-linked N-acetylglucosamine transferase (OGT) is overexpressed and promotes O-linked protein glycosylation in esophageal squamous cell carcinoma |
| Q36383931 | OBAYA (obesity and adverse health outcomes in young adults): feasibility of a population-based multiethnic cohort study using electronic medical records |
| Q34238737 | Obesity adversely affects survival in pancreatic cancer patients |
| Q39024774 | Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation |
| Q36734737 | Obesity and Cancer: Concepts and Challenges |
| Q35817986 | Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality |
| Q39026659 | Obesity and Endometrial Cancer |
| Q48241850 | Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study |
| Q28078567 | Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation |
| Q37947906 | Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin |
| Q37200502 | Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients |
| Q90179733 | One week of continuous corticosterone exposure impairs hepatic metabolic flexibility, promotes islet β-cell proliferation, and reduces physical activity in male C57BL/6 J mice |
| Q40111911 | Outcomes of preexisting diabetes mellitus in breast, colorectal, and prostate cancer. |
| Q38081505 | Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer |
| Q38043963 | Perceived impact of cancer treatment on diabetes self-management. |
| Q37367482 | Poor Preoperative Glycemic Control Is Associated with Dismal Prognosis after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Korean Multicenter Study |
| Q33751641 | Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. |
| Q90055018 | Pre- and Post-diagnosis Diabetes as a Risk Factor for All-Cause and Cancer-Specific Mortality in Breast, Prostate, and Colorectal Cancer Survivors: a Prospective Cohort Study |
| Q47238502 | Pre-existing diabetes mellitus and all-cause mortality in cancer patients: a register-based study in Latvia |
| Q48651168 | Pre-existing diabetes mellitus in patients with multiple myeloma |
| Q34328991 | Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis |
| Q36152708 | Pre-existing type 2 diabetes mellitus is an independent risk factor for mortality and progression in patients with renal cell carcinoma. |
| Q50971850 | Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study. |
| Q36659645 | Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients |
| Q48840907 | Predictors of survival for patients with cancer after cryptogenic stroke |
| Q37269514 | Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes |
| Q88798020 | Preventable Diabetic Complications After a Cancer Diagnosis in Patients With Diabetes: A Population-Based Cohort Study |
| Q35798114 | Prioritization of care in adults with diabetes and comorbidity |
| Q24645449 | Prognosis of hormone-dependent breast cancers: implications of the presence of dysfunctional transcriptional networks activated by insulin via the immune transcription factor T-bet |
| Q36315921 | Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study |
| Q83979505 | Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes |
| Q40957665 | Prognostic relevance of preoperative diabetes mellitus and the degree of hyperglycemia on the outcomes of resected pancreatic ductal adenocarcinoma |
| Q35874455 | Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer |
| Q37407105 | Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment. |
| Q38993013 | Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy |
| Q36678127 | Quality of care for comorbid conditions during the transition to survivorship: differences between cancer survivors and noncancer controls |
| Q57020576 | Quality of diabetes care in breast, colorectal, and prostate cancer |
| Q64929524 | Quality of diabetes care in cancer: a systematic review. |
| Q46076662 | RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice. |
| Q34424031 | Relationship between diabetes and risk of second primary contralateral breast cancer |
| Q60922756 | Remodeling the Microenvironment before Occurrence and Metastasis of Cancer |
| Q57076958 | Report of the JDS/JCA Joint Committee on Diabetes and Cancer |
| Q50488148 | Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer. |
| Q65002577 | Resistance Exercise Training as a Primary Countermeasure to Age-Related Chronic Disease. |
| Q44029603 | Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients |
| Q90394777 | Rice intake and risk of type 2 diabetes: the Singapore Chinese Health Study |
| Q64230426 | Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis |
| Q33962303 | Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV. |
| Q38398847 | Risk of cause-specific death in individuals with cancer - modifying role diabetes, statins, and metformin |
| Q33817206 | Role of metformin in suppressing 1,2-dimethylhydrazine-induced colon cancer in diabetic and non-diabetic mice: effect on tumor angiogenesis and cell proliferation |
| Q64963064 | Semaglutide s.c. Once-Weekly in Type 2 Diabetes: A Population Pharmacokinetic Analysis. |
| Q33737320 | Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. |
| Q36923125 | Should diabetic women with breast cancer have their own intervention studies? |
| Q33585663 | Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians |
| Q55212706 | Stearoyl-CoA desaturase-1 promotes colorectal cancer metastasis in response to glucose by suppressing PTEN. |
| Q47133179 | Survival benefits in colorectal adenocarcinoma with the use of metformin among a black diabetic inner city population |
| Q35125031 | Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis |
| Q35153493 | Survival of patients with stage IV lung cancer with diabetes treated with metformin |
| Q35249824 | Switching the sphingolipid rheostat in the treatment of diabetes and cancer comorbidity from a problem to an advantage |
| Q36863215 | Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer |
| Q38016107 | Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects |
| Q36680139 | Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression |
| Q37206482 | The Effect of Diabetes Mellitus on Lung Cancer Prognosis: A PRISMA-compliant Meta-analysis of Cohort Studies |
| Q90529107 | The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis |
| Q34561879 | The Future of Cancer Survivorship Care for Veterans |
| Q52324116 | The Impact of Obesity on Breast Cancer. |
| Q64972488 | The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation. |
| Q37193603 | The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study |
| Q36919504 | The Role of Insulin and Insulin-like Growth Factors in the Increased Risk of Cancer in Diabetes |
| Q46142571 | The Role of Type 2 Diabetes for the Development of Pathogen-Associated Cancers in the Face of the HIV/AIDS Epidemic. |
| Q50947162 | The association between diabetes and breast cancer stage at diagnosis: a population-based study. |
| Q27026813 | The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms |
| Q64047001 | The association of betel quid, alcohol, and cigarettes with salivary gland tumor-A case-control study |
| Q35500732 | The burden of cancer risk in Canada's indigenous population: a comparative study of known risks in a Canadian region |
| Q34510892 | The diabetes-cancer link |
| Q38243241 | The epidemiology of diabetes and cancer |
| Q64915919 | The impact of cancer on diabetes outcomes. |
| Q46776885 | The impact of diabetes mellitus on breast cancer outcomes: a single center retrospective study |
| Q39432270 | The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer |
| Q83209166 | The impact of diabetes on survival in women with ovarian cancer |
| Q35219593 | The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer |
| Q44583136 | The impact of type 2 diabetes on the outcome of localized renal cell carcinoma |
| Q36499082 | The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer |
| Q44913921 | The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer |
| Q55690351 | The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression. |
| Q36347687 | The insulin response integrates increased TGF-β signaling through Akt-induced enhancement of cell surface delivery of TGF-β receptors |
| Q89520986 | The prognostic significance of preexisting diabetes in patients with surgically treated renal cell carcinoma: the ongoing debate |
| Q34113485 | The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies. |
| Q37430013 | Time to follow-up of an abnormal mammogram in women with diabetes: a population-based study |
| Q86508042 | Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus |
| Q36870182 | Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies |
| Q37238181 | Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling |
| Q90063987 | Treatment Patterns for Chronic Comorbid Conditions in Patients With Cancer Using a Large-Scale Observational Data Network |
| Q90070289 | Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015 |
| Q37301937 | Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population |
| Q33756414 | Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy |
| Q50020860 | Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort |
| Q58113108 | Type 2 diabetes as a predictor of survival among breast cancer patients: the multiethnic cohort |
| Q90599807 | Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma |
| Q48953480 | Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma |
| Q82505332 | Type 2 diabetes mellitus and prognosis in early stage breast cancer women |
| Q38835481 | Type 2 diabetes, insulin treatment and prognosis of breast cancer |
| Q37651046 | Undiagnosed diabetes in breast, colorectal, lung, and prostate cancer: incidence and risk factors. |
| Q41573344 | What causes international variations in length of stay: a comparative analysis for two inpatient conditions in Japanese and Canadian hospitals. |
Search more.